Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a history of exacerbations. Daliresp is also referred to by its drug name, Roflumilast.

Daliresp is a phosphodiesterase inhibitor. Daliresp is believed to work by decreasing the amount of certain molecules that cause inflammation.

How do I take it?
Prescribing information states that Daliresp is generally taken once daily.

Daliresp comes in tablet form.

Side effects... read more

The FDA-approved label for Daliresp lists common side effects including dizziness, decreased appetite, diarrhea, weight loss, nausea, back pain, flu-like symptoms, and trouble sleeping.

Rare but serious side effects listed for Dailyresp include suicidal thinking and weight loss.

Links:

Dailiresp
https://www.daliresp.com

Daliresp (Roflumilast) Questions

Continue with Facebook
Sign up with your email
Already a Member? Log in